ContextType 1 diabetes mellitus (DM) results from a cell-mediated autoimmune attack
against pancreatic beta cells. Previous animal and clinical studies suggest that moderate …

Context In 2007, the effects of the autologous nonmyeloablative hematopoietic stem cell
transplantation (HSCT) in 15 patients with type 1 diabetes mellitus (DM) were reported. Most …

Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell
transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The …

Studies have shown that autologous hematopoietic SCT (HSCT) can be used as an
intensive immunosuppressive therapy to treat refractory patients and to prevent the …

Autologous hematopoietic stem cell transplantation (AHSCT) increases C-peptide levels
and induces insulin independence in patients with type 1 diabetes. This study aimed to …

In this review, we present (1) the scientific basis for the use of high‐dose
immunosuppression followed by autologous peripheral blood hematopoietic stem cell …

The aim of this work is to simulate and compare the energy savings potentially applicable to
the consumption data of the Smart Street pilot system located at the ENEA Casaccia RC …

Lipoatropic diabetes (LD) designates a group of syndromes characterized by diabetes
mellitus with marked insulin resistance and either a localized or generalized absence of …

The SARS-CoV-2 pandemic have been affecting millions of people worldwide, since the
beginning of 2020. COVID-19 can cause a wide range of clinical symptoms, which varies …

Autologous haematopoietic stem-cell transplantation (AHSCT) has been experimented as a
treatment in patients affected by severe forms of multiple sclerosis (MS) who failed to …